We are live on ! Find out more
RCM

Raleigh Capital Management Portfolio holdings

AUM $313M
1-Year Est. Return 23.55%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
10 Year Est. Return
AUM
$215M
AUM Growth
+$19.2M
Cap. Flow
+$2.18M
Cap. Flow %
1.01%
Top 10 Hldgs %
21.42%
Holding
1,200
New
251
Increased
427
Reduced
249
Closed
121

Sector Composition

Rank Sector Weight
1 Financials 9.37%
2 Technology 8.08%
3 Healthcare 7.63%
4 Utilities 7.47%
5 Consumer Staples 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
401
TG Therapeutics
TGTX
$7.62B
$24.4K 0.01%
1,428
+200
+16% +$2.32K
WELL icon
402
Welltower
WELL
$171B
$24.4K 0.01%
270
+31
+13% +$2.69K
UNM icon
403
Unum
UNM
$14.3B
$24.3K 0.01%
537
-45
-8% -$2.05K
ARVN icon
404
Arvinas
ARVN
$572M
$24.2K 0.01%
+589
New +$13.8K
FTSM icon
405
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
$24.2K 0.01%
407
-371
-48% -$22.1K
YUM icon
406
Yum! Brands
YUM
$41.1B
$24.2K 0.01%
185
+1
+0.5% +$125
DE icon
407
Deere & Co
DE
$168B
$24.2K 0.01%
60
-45
-43% -$17K
GAP
408
The Gap Inc
GAP
$7.37B
$24.1K 0.01%
+1,151
New +$18.6K
ITT icon
409
ITT
ITT
$19.1B
$24K 0.01%
201
-20
-9% -$2.1K
PRI icon
410
Primerica
PRI
$9.89B
$24K 0.01%
116
-15
-11% -$3.06K
ADM icon
411
Archer Daniels Midland
ADM
$36.9B
$23.9K 0.01%
332
+17
+5% +$1.24K
NU icon
412
Nu Holdings
NU
$66.9B
$23.8K 0.01%
2,856
-166
-5% -$1.34K
AIZ icon
413
Assurant
AIZ
$14.3B
$23.7K 0.01%
141
+109
+341% +$17.3K
FPE icon
414
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$23.6K 0.01%
1,399
+19
+1% +$307
POR icon
415
Portland General Electric
POR
$5.77B
$23.6K 0.01%
544
+159
+41% +$6.6K
CNM icon
416
Core & Main
CNM
$8.71B
$23.2K 0.01%
+573
New +$19.4K
FDD icon
417
First Trust STOXX European Select Dividend Income Fund
FDD
$911M
$23.1K 0.01%
1,909
-46
-2% -$513
ORI icon
418
Old Republic International
ORI
$10.4B
$23K 0.01%
783
-72
-8% -$2.02K
KHC icon
419
Kraft Heinz
KHC
$30B
$22.9K 0.01%
620
+115
+23% +$3.91K
ACGL icon
420
Arch Capital
ACGL
$33.6B
$22.6K 0.01%
305
+47
+18% +$3.84K
OC icon
421
Owens Corning
OC
$12.4B
$22.3K 0.01%
150
+25
+20% +$3.31K
ELAN icon
422
Elanco Animal Health
ELAN
$11.1B
$21.9K 0.01%
1,470
-570
-28% -$6.46K
PDBC icon
423
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.42B
$21.8K 0.01%
1,635
+662
+68% +$9.49K
RRC icon
424
Range Resources
RRC
$8.95B
$21.6K 0.01%
710
-79
-10% -$2.59K
GE icon
425
GE Aerospace
GE
$384B
$21.4K 0.01%
211
+163
+340% +$15.1K

Similar funds

Raleigh Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Raleigh Capital Management held 1,200 positions worth $215M, up 9.8% from $196M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raleigh Capital Management's Q4 2023 filing shows 251 new, 427 increased, 249 reduced and 121 closed positions. Its largest new stake was iShares Core High Dividend ETF: 61,730 shares worth $1.26M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $3.51M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.6% a quarter earlier, followed by Technology and Healthcare.

  • Raleigh Capital Management's largest Q4 2023 buy was iShares Core High Dividend ETF: 61,730 shares worth $1.26M.
  • Raleigh Capital Management added most to Invesco QQQ Trust in Q4 2023, an estimated $3.27M increase.
  • Raleigh Capital Management's biggest Q4 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.51M.
  • Raleigh Capital Management fully exited FT Vest US Equity Buffer ETF February in Q4 2023, selling an estimated $235K.
  • Raleigh Capital Management's ten largest holdings make up 21% of its $215M portfolio in Q4 2023.
  • Raleigh Capital Management opened 251 new positions and closed 121 in Q4 2023.
  • Raleigh Capital Management's portfolio value rose 9.8% quarter-over-quarter to $215M.

Based on Raleigh Capital Management's 13F filing for Q4 2023, filed 21 Feb 2024.